Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days’ gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
Monica Dragoman(Gynuity Health Projects), Anand Tamang(Ministry of Health and Population), Nguyen My Huong(World Health Organization), Daniel Grossman(University of California, San Francisco), Ndema Habib(World Health Organization), Nathalie Kapp(International Planned Parenthood Federation), Duong Lan Dung(Vietnam National Children's Hospital)
Cited by 7
Related Papers
Medical methods for first trimester abortion
|Cochrane Database of Systematic Reviews|2011|288
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
|Reproductive Health|2013|161
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
|The Journal of Clinical Endocrinology & Metabolism|2016|139